VolitionRx Limited
$0.28
$0.01 (+3.64%)
$0.27Day Range$0.30
Key Statistics
Market Cap
$7.67M
Shares Outstanding
27.9M
Primary Exchange
XASE
Currency
USD
Type
CS
IPO Date
Apr 25, 2007
Round Lot
100
Locale
US
Trading Data
Day Open
$0.29
Day High
$0.30
Day Low
$0.27
Volume
28.23M
VWAP
$0.31
Prev Close
$0.27
Transactions
--
Acc. Volume
--
About VolitionRx Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCESSIC 283575 employees1489 WEST WARM SPRINGS ROAD, HENDERSON, NV, 890141 (512) 774-8930IPO Apr 25, 2007US / STOCKSActiveWebsite
Identifiers
- CIK
- 0000093314
- Composite FIGI
- BBG000BQWFH2
- Share Class FIGI
- BBG001SDZ7B2
- Ticker Root
- VNRX
- SIC Code
- 2835
About VolitionRx Limited (VNRX) Stock
VolitionRx Limited (VNRX) closed the 2026-09-17 session at $0.28, up 3.64% versus the previous close (+0.01). The stock opened at $0.29 and traded between $0.27 and $0.30 during that session. Session trading volume was 28.2M shares. The volume-weighted average price (VWAP) is $0.31.
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.
VolitionRx Limited has a market capitalization of $7.7 million. The company operates in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES industry classification. VNRX is listed on the XASE exchange. The company employs approximately 75 people. VolitionRx Limited is headquartered in HENDERSON, NV. The recorded listing date is 2007-04-25.
On this page you can find market VNRX stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector.